Annual Retained Earnings
-$89.42 M
-$43.55 M-94.96%
December 31, 2023
Summary
- As of February 20, 2025, DNTH annual retained earnings is -$89.42 million, with the most recent change of -$43.55 million (-94.96%) on December 31, 2023.
- During the last 3 years, DNTH annual retained earnings has fallen by -$72.03 million (-414.16%).
- DNTH annual retained earnings is now -414.16% below its all-time high of -$17.39 million, reached on December 31, 2021.
Performance
DNTH Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$145.95 M
-$25.17 M-20.84%
September 30, 2024
Summary
- As of February 20, 2025, DNTH quarterly retained earnings is -$145.95 million, with the most recent change of -$25.17 million (-20.84%) on September 30, 2024.
- Over the past year, DNTH quarterly retained earnings has dropped by -$67.09 million (-85.08%).
- DNTH quarterly retained earnings is now -218.20% below its all-time high of -$45.87 million, reached on December 31, 2022.
Performance
DNTH Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DNTH Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.0% | -85.1% |
| 3 y3 years | -414.2% | -85.1% |
| 5 y5 years | -414.2% | -85.1% |
DNTH Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -414.2% | at low | -218.2% | at low |
| 5 y | 5-year | -414.2% | at low | -218.2% | at low |
| alltime | all time | -414.2% | at low | -218.2% | at low |
Dianthus Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$145.95 M(+20.8%) |
| Jun 2024 | - | -$120.78 M(+17.1%) |
| Mar 2024 | - | -$103.17 M(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$89.42 M(+95.0%) | -$89.42 M(+13.4%) |
| Sep 2023 | - | -$78.86 M(+71.9%) |
| Dec 2022 | -$45.87 M(+163.7%) | -$45.87 M |
| Dec 2021 | -$17.39 M | - |
FAQ
- What is Dianthus Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual retained earnings year-on-year change?
- What is Dianthus Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly retained earnings year-on-year change?
What is Dianthus Therapeutics annual retained earnings?
The current annual retained earnings of DNTH is -$89.42 M
What is the all time high annual retained earnings for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual retained earnings is -$17.39 M
What is Dianthus Therapeutics annual retained earnings year-on-year change?
Over the past year, DNTH annual retained earnings has changed by -$43.55 M (-94.96%)
What is Dianthus Therapeutics quarterly retained earnings?
The current quarterly retained earnings of DNTH is -$145.95 M
What is the all time high quarterly retained earnings for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly retained earnings is -$45.87 M
What is Dianthus Therapeutics quarterly retained earnings year-on-year change?
Over the past year, DNTH quarterly retained earnings has changed by -$67.09 M (-85.08%)